Bullish flow in Novo Nordisk (NVO), with shares up $2.54, or 4.88%, near $54.53. Options volume running well above average with 139k contracts traded and calls leading puts for a put/call ratio of 0.26, compared to a typical level near 0.74. Implied volatility (IV30) is higher by 2.3 points near 45.59,and above the 52wk median, suggesting an expected daily move of $1.57. Put-call skew flattened, suggesting a modestly bullish tone, following an upgrade to Neutral at BNP Paribas Exane.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Dayforce said in talks to be acquired, Soho House to go private: Morning Buzz
- Eli Lilly Signs $1.3 Billion Deal with Superluminal to Discover Future Drugs Using AI
- Unusually active option classes on open August 18th
- Hims & Hers down 2% as GoodRx expands Ozempic, Wegovy access
- GoodRx enters pact with Novo Nordisk to expand Ozempic, Wegovy access